Y Combinator-backed NxtCure Labs launches AI CRO with cancer digital twins
ycombinator · x · 2026-11-12
NxtCure Labs, backed by Y Combinator, just launched as an AI CRO using digital twins to test cancer drugs before they reach patients, claiming to be 28% better than even the best frontier AI models.
The startup targets oncology trial pain points: trials take 10+ years, 3% of drugs get approved, and 90%+ fail post-animal testing. Its goal is helping new oncology drugs get through trials faster.
More from Companies & People
- Peter Yang flags broken Claude app remote-control threads and widget bugs — petergyang · 2026-11-12
- Cohere Chief AI Officer Joelle Pineau named to Forbes CIO Next list — cohere · 2026-11-12
- Developer on learning LLMs by building from scratch with Raschka's book — rasbt · 2026-11-12
- Organizing 55k data points is easy: enterprise data prep for agents is the hard part — BenBajarin · 2026-11-12
- Midjourney's David Holz on why grand goals mean no project ever feels finished — DavidSHolz · 2026-11-12
- Business strategy debate: hide the AI behind humans, not humans behind AI — annetgriffin · 2026-11-12